A novel form of docetaxel polymeric micelles demonstrates anti-tumor and ascites-inhibitory activities in animal models as monotherapy or in combination with anti-angiogenic agents

HIGHLIGHTS

• who: August and colleagues from the Indian Institute of Technology University of South Florida have published the Article: A novel form of docetaxel polymeric micelles demonstrates anti-tumor and ascites-inhibitory activities in animal models as monotherapy or in combination with anti-angiogenic agents, in the Journal: (JOURNAL)
• what: The authors determined the effectiveness of a novel docetaxel micelle HT001 in 2 preclinical ascites formation mouse models as well as multiple solid tumor subcutaneous xenograft mouse models. The study demonstrates the potential clinical utility of HT001 in combination with anti-angiogenic therapy in the treatment . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.